- Home
- QNCX vs HIT Comparison
QNCX vs HIT Comparison
Compare QNCX & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QNCX | HIT |
|---|---|---|
| Founded | 2012 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.2M | 152.4M |
| IPO Year | 2019 | 2024 |
Fundamental Metrics
Financial Performance| Metric | QNCX | HIT |
|---|---|---|
| Price | $3.80 | $1.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $7.75 | $2.50 |
| AVG Volume (30 Days) | ★ 1.1M | 488.0K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $30,723,490.00 |
| Revenue This Year | N/A | $70.02 |
| Revenue Next Year | N/A | $44.08 |
| P/E Ratio | ★ N/A | $50.12 |
| Revenue Growth | N/A | ★ 55.15 |
| 52 Week Low | $0.72 | $0.51 |
| 52 Week High | $4.55 | $7.59 |
Technical Indicators
Market Signals| Indicator | QNCX | HIT |
|---|---|---|
| Relative Strength Index (RSI) | 64.26 | 38.05 |
| Support Level | $3.74 | $1.03 |
| Resistance Level | $4.55 | $1.16 |
| Average True Range (ATR) | 0.46 | 0.16 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 64.39 | 30.28 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About HIT Health In Tech Inc.
Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.